Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec:196:111300.
doi: 10.1016/j.colsurfb.2020.111300. Epub 2020 Aug 23.

Interfacial tension effects on the properties of PLGA microparticles

Affiliations
Review

Interfacial tension effects on the properties of PLGA microparticles

Andrew Otte et al. Colloids Surf B Biointerfaces. 2020 Dec.

Abstract

Many types of long-acting injectables, including in situ forming implants, preformed implants, and polymeric microparticles, have been developed and ultimately benefited numerous patients. The advantages of using long-acting injectables include greater patient compliance and more steady state drug plasma levels for weeks and months. However, the development of long-acting polymeric microparticles has been hampered by the lack of understanding of the microparticle formation process, and thus, control of the process. Of the many parameters critical to the reproducible preparation of microparticles, the interfacial tension (IFT) effect is an important factor throughout the process. It may influence the droplet formation, solvent extraction, and drug distribution in the polymer matrix, and ultimately drug release kinetics from the microparticles. This mini-review is focused on the IFT effects on drug-loaded poly(lactic-co-glycolic acid) (PLGA) microparticles.

Keywords: Interfacial tension; PLGA microparticles; Processing parameters; Solvent extraction.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Three main types of w/o/w emulsions: microcapsule (a), multi-vesicular (b), and matrix or monolithic (c) structures.
Figure 2.
Figure 2.
Potential phase configurations at equilibrium in relation to the spreading coefficient. (a) Full engulfment (i.e., core shell) (S1 < 0, S2 < 0, S3 > 0); (b) Partial engulfment (i.e., Janus) (S1 < 0, S2 < 0, S3 < 0); (c) No engulfment (i.e., individual particles) (S1 < 0, S2 > 0, S3 < 0). Scanning electron microscopy (SEM) images of PLGA/polycaprolactone microparticles formed with the polymer weight ratio of 19:11, (d) without drug; with drugs, i.e. (e) glibenclamide (negatively charged); (f) rapamycin (no charge); and (g) lidocaine (positively charged). Reproduced with permission [64].

References

    1. Gilding DK, Reed AM, Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1, Polymer, 20 (1979) 1459–1464.
    1. Kulkarni RK, Pani KC, Neuman C, Leonard F, Polylactic Acid for Surgical Implants, JAMA Surgery, 93 (1966) 839–843. - PubMed
    1. Cutright DE, Hunsuck EE, Tissue reaction to the biodegradable polylactic acid suture, Oral Surgery, Oral Medicine, Oral Pathology, 31 (1971) 134–139. - PubMed
    1. Cutright DE, Hunsuck EE, Beasley JD, Fracture reduction using a biodegradable material, polylactic acid, Journal of oral surgery (American Dental Association : 1965), 29 (1971) 393. - PubMed
    1. Makadia HK, Siegel SJ, Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier, Polymers, 3 (2011) 1377–1397. - PMC - PubMed

Substances

LinkOut - more resources